You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ponatinib

Showing 1 - 25 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Jena, Germany
      University Hospital Jena
    Jan 17, 2023

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

    Recruiting
    • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    • Frankfurt, Germany
      Department of Medicine, Hematology and Oncology, Goethe Universi
    Sep 24, 2023

    Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

    Completed
    • Leukemia
    • No Intervention
    • Cambridge, Massachusetts
      Takeda
    Feb 28, 2023

    Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Leukemia
    • Ponatinib
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 23, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • +2 more
    • Ponatinib 15 MG Oral Tablet
    • Brno, Czechia
    • +6 more
    Nov 30, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    ALL Trial in Spain (Prednisone, Vincristine, Daunorubicin)

    Active, not recruiting
    • ALL
    • Badalona, Spain
    • +9 more
    Feb 17, 2022

    Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

    Terminated
    Has Results
    • Chronic Phase Chronic Myeloid Leukemia
    • Ponatinib 30 mg QD
    • +2 more
    • Bruxelles, Belgium
      Cliniques Universitaire Saint-Luc (Site 058)
    Oct 28, 2021

    Medullary Thyroid Cancer Trial (Ponatinib)

    Withdrawn
    • Medullary Thyroid Cancer
    • Ponatinib
    • (no location specified)
    Oct 6, 2021

    Non Small Cell Lung Cancer, KRAS Gene Mutation Trial in United States (Trametinib 0.5 mg, Trametinib 1 MG, Trametinib 1.5 MG)

    Completed
    • Non Small Cell Lung Cancer
    • KRAS Gene Mutation
    • Trametinib 0.5 mg
    • +5 more
    • Basking Ridge, New Jersey
    • +6 more
    Feb 7, 2022

    Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora

    Completed
    Has Results
    • Adenocarcinoma of the Lung
    • +7 more
    • Ponatinib
    • Aurora, Colorado
      University of Colorado Cancer Center
    Jan 19, 2022

    Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)

    Active, not recruiting
    • Leukemia, Myeloid, Chronic-Phase
    • Ponatinib
    • Halle (Saale), Saxony-Anhalt, Germany
    • +9 more
    Sep 9, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +7 more
    • Blinatumomab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    CML Patients in the National Compassionate Program

    Terminated
    • Chronic Myeloid Leukemia
    • Philadelphia Positive
    • Ponatinib
    • Bari, Italy
    • +9 more
    Oct 24, 2022

    Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Nov 28, 2022

    Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

    Active, not recruiting
    • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2022

    Chronic Myeloid Leukemia, Chronic Phase Trial in Spain (Ponatinib 15 MG, Acetylsalicylic acid 100 MG)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Ponatinib 15 MG
    • Acetylsalicylic acid 100 MG
    • L'Hospitalet De Llobregat, Barcelona, Spain
    • +12 more
    Feb 8, 2022

    Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Ponatinib
    • Ghent, Belgium
    • +28 more
    Nov 11, 2022

    Landscape and Real-life Treatment Outcomes in Hungary: Analysis

    Completed
    • Chronic Myeloid Leukaemia
    • Budapest, Hungary
      Pfizer
    Dec 15, 2022

    Leukemia, Myeloid, Acute Trial in France (Ponatinib 30 MG)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Ponatinib 30 MG
    • Angers, France
    • +13 more
    Aug 4, 2021

    Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

    Recruiting
    • Philadelphia Chromosome Positive CML
    • BCR-ABL Positive Chronic Myelogenous Leukemia
    • Amiens, France
    • +27 more
    Dec 9, 2021

    Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL Trial in Italy (Ponatinib

    Recruiting
    • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
    • +2 more
    • Ponatinib + Blinatumomab
    • Chemotherapy + Imatinib
    • Ascoli Piceno, Italy
    • +14 more
    Jan 3, 2022

    Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse Trial in Italy (Ponatinib)

    Recruiting
    • Philadelphia-Positive ALL
    • Acute Lymphoblastic Leukemia, in Relapse
    • Ponatinib
    • Ancona, Italy
    • +21 more
    Jan 3, 2022